*To the Editor:* Mucormycosis and aspergillosis are opportunistic fungal infections that can lead to life-threatening complications.^\[[@R1],[@R2]\]^ Pulmonary actinomycosis is a rare infection which is commonly confused with other lung diseases.^\[[@R3]\]^ Co-infection with these three pathogens in the same host is rare. Here, we report a unique case of a cavitary lesion with aspergillosis, mucormycosis, and actinomycosis co-infection.

A 52-year-old male patient with type 2 diabetes presented at Fujian Medical University Union Hospital with a 2-month history of fever, cough, expectoration, and muscle soreness. Chest computed tomography (CT) scans revealed a large irregular cavitary lesion in his right upper lobe (RUL) \[Figure [1](#F1){ref-type="fig"}A\]. Following antibacterial therapy, CT showed that his lobar pneumonia had partially disappeared but lung abscesses had formed \[Figure [1](#F1){ref-type="fig"}B\]. The sound from his right lung was slightly quieter than from the left lung; moist rales were heard from both sides.

![Chest computed tomography (A--D), bronchoscopic (E--G), and pathologic findings (H--J) of the patient. (A) An infectious lesion in the RUL with a small amount of pleural effusion on the right-hand side. (B) Following 1 week of treatment with antibiotics, the lobar pneumonia was partially absorbed but a lung abscess was visible. (C) An irregular cavity with a thick wall in the RUL. (D) Bilateral pneumonia, particularly in the right and left lower-lobes; a cavity was found in the RUL accompanied by right-lung consolidation and an air bronchogram. (E) Stenosis of the bronchial opening in the RUL with a coarse mucous membrane, which was blocked by a large amount of purulent yellow sputum. (F) The bronchus in the RUL was completely obstructed by a granulomatous neoplasm which was covered by a sputum scab; the surrounding mucous membrane was coarse, congestive, and swelling. (G) The bronchus in the RUL was completely obstructed by a yellowish granulomatous neoplasm with a coarse surface, which floated up and down with respiration. (H) Fungal mycelia were observed which appeared to be *Mucor* (hematoxylin-eosin staining, original magnification ×10). (I) *Aspergillus* with multiple septate filaments (hematoxylin-eosin staining, original magnification ×40). (J) Fungal mycelia were observed in the background and identified as *Actinomycetes* (hematoxylin-eosin staining, original magnification ×4). RUL: Right upper lung.](cm9-132-2512-g001){#F1}

Investigations showed elevated leukocytes (15.31 × 10^9^/L) and serum creatinine (178 μmol/L), plus hypoxemia (arterial partial pressure of oxygen \[PaO~2~\] 66.6 mmHg). He had poor blood-glucose control (glycosylated hemoglobin 8.3%). Serum procalcitonin, fungal glucan, and *Cryptococcus* capsule antigen tests were negative. A serum galactomannan test (GM test) was positive (0.56). No pathogens were detected in sputum sample cultures, although *Candida albicans* was cultured (100 cfu/mL). Sputum smears for acid-fast bacilli and cancer cells were negative. Bronchoscopy revealed purulent sputum blocking the RUL bronchus \[Figure [1](#F1){ref-type="fig"}E\]. A bronchoalveolar lavage fluid (BALF) GM test was positive (4.51). Microbiology/pathology results confirmed aspergillosis infection.

The patient received meropenem and voriconazole for 2 weeks while aspergillosis was confirmed. CT revealed an irregular thick-walled cavity in the RUL \[Figure [1](#F1){ref-type="fig"}C\]. Oral voriconazole was continued. One month later, another bronchoscopy showed the RUL bronchus was completely obstructed by a granulomatous neoplasm \[Figure [1](#F1){ref-type="fig"}F\]; BALF GM test was positive (1.78). Pathologic results were different, with fungal mycelia observed, including *Mucor* \[Figure [1](#F1){ref-type="fig"}H\] and *Aspergillus* \[Figure [1](#F1){ref-type="fig"}I\]. Mucormycosis was confirmed; therefore, we recommended amphotericin B or posaconazole; the patient refused because he had renal dysfunction.

His intermittent fever remained; coughing, shortness of breath, and pneumonia worsened \[Figure [1](#F1){ref-type="fig"}D\]; blood creatinine increased to 260 μmol/L. Meropenem and posaconazole were given. Bronchoscopy showed the RUL bronchus completely obstructed by a yellowish granulomatous neoplasm which moved up and down as he respired \[Figure [1](#F1){ref-type="fig"}G\]. A further BALF GM test was positive (5.09). Pathology showed that fungal mycelia of *Aspergillus* were observed in the background of *Actinomycetes* \[Figure [1](#F1){ref-type="fig"}J\]. The patient refused amphotericin B again; piperacillin-tazobactam was substituted for meropenem and oral posaconazole was continued.

After 6 months, no improvement was seen, so pulmonary lobectomy was performed. Post-operative pathology showed a mycotic mass of *Aspergillus*. The patient went into remission.

Mucormycosis and aspergillosis are opportunistic, potentially fatal invasive fungal infections; co-infection usually occurs in the orofacial area or sinuses.^\[[@R1],[@R2]\]^ Pulmonary actinomycosis is rare and frequently confused with other pulmonary diseases; therefore, correct diagnosis is challenging, often leading to delayed or misdiagnosis.^\[[@R3]\]^ Treatment of such co-infections requires prompt diagnosis, appropriate treatment, and, if necessary, surgical resection.
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